Doximity stock jumps 81% on AI Search guidance raise
Plus: GoodRx beats and raises on Pharma Direct growth. The day's rules, money, and enforcement, sourced and tiered below.
Plus: GoodRx beats and raises on Pharma Direct growth. The day's rules, money, and enforcement, sourced and tiered below.
|
American Health Intel
Rules · Money · Medicine · Decoded daily
|
| The Ledger |
Friday, August 7, 2026 |
|
|
Doximity stock jumps 81% on AI Search guidance raise
|
|
Plus: GoodRx beats and raises on Pharma Direct growth. The day's rules, money, and enforcement, sourced and tiered below.
|
|
|
Earnings Confidence: High
Doximity, the professional network used by most U.S. physicians, saw its stock jump as much as 81 percent on a fiscal Q1 beat and a guidance raise built on an unbooked pharma AI ad product.
Revenue hit 156.6 million dollars and full-year guidance rose to 671 to 681 million dollars. The company recognized zero dollars from AI Search this quarter, meaning investors are pricing an entirely unbooked revenue line.
|
Why it matters
A digital health company's stock jumped sharply on earnings, but the guidance raise leans on a new AI advertising product that has not yet booked revenue, so watch whether it delivers.
|
|
|
Earnings Confidence: High
GoodRx, the prescription discount and price-comparison app, beat second-quarter estimates and raised full-year guidance even as its original discount-card business kept shrinking.
Legacy prescription-transaction revenue fell 26 percent to 106.4 million dollars. Pharma Direct, GoodRx's manufacturer-funded discount channel, grew 76 percent to 61.6 million dollars and now drives the growth story.
|
Why it matters
A consumer drug discount app's original business is shrinking while a pharma funded channel takes over as its growth engine.
|
|
|
Also today
iRhythm buys VitalConnect for $287.5M Read
FRONTIER SCAN: California widens corporate-practice-of-medicine crackdown Read
Lane Regional Medical Center cuts 18 jobs, closes specialty clinic Read
UMass Memorial Health co-leads Wellinks' $10M Series B Read
|
435 Records | $31.7B Enforcement | 19 Deadlines | 126 Rules |
|
|
Pick your field on the site and every story tells you what it means for you.
|
|
Reply to this email and tell us what you want covered. We read everything.
|
|
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe
|
|